Dapagliflozin Does Not Directly Affect Human α or β Cells
Dai, Chunhua;Walker, John T;Shostak, Alena;Bouchi, Yasir;Poffenberger, Greg;Hart, Nathaniel J;Jacobson, David A;Calcutt, M Wade;Bottino, Rita;Greiner, Dale L;Shultz, Leonard D;McGuinness, Owen P;Dean, E Danielle;Powers, Alvin C;
endocrinology2020Vol. 161pp. -
103
chunhua2020endocrinologydapagliflozin
Abstract
Abstract. Selective inhibitors of sodium glucose cotransporter-2 (SGLT2) are widely used for the treatment of type 2 diabetes and act primarily to lower blood